Trump tariffs weigh on Brazil chemical exporters, spark order cancellations

Brazilian chemical companies are experiencing immediate contract cancellations and revoked export financing in anticipation of President Trump's threatened 50% tariff on Brazilian exports to the U.S. from August 1. This impacts a sector that exported $2.4 billion to the U.S. last year, with broader implications for other Brazilian industries reliant on chemicals (e.g., plywood, orange juice) and U.S. companies with operations in Brazil like Dow and Exxon Mobil. Brazil's chemical lobby, Abiquim, argues the tariffs are unjustified, citing the sector's $7.9 billion trade deficit with the U.S.

Analysis

A threatened 50% U.S. tariff on Brazilian exports is causing immediate and significant disruption in the Brazilian chemical sector, which exported $2.4 billion to the United States last year. According to the Brazilian chemical lobby Abiquim, market participants are treating the threat as credible, leading to a wave of pre-emptive contract cancellations and the revocation of secured export financing before the tariff's proposed August 1 implementation. The impact extends beyond direct chemical exports, creating negative second-order effects for other Brazilian export-oriented industries such as agriculture, plywood, and orange juice, which depend on these chemicals in their production processes. The situation creates direct risk for companies with substantial Brazilian operations; Dow Inc. (DOW), with its 10 local plants and exports of silicon metal for processing in the U.S., is noted as particularly exposed. Brazilian firm Braskem (BAK) is also directly affected. Abiquim contends the tariffs are unjustified, citing the sector's existing $7.9 billion trade deficit with the U.S., which highlights the potential for significant and contentious trade friction.

Key Decisions for Investors

• Investors with exposure to Dow Inc. (DOW) and Braskem (BAK) should re-evaluate their positions given the material risk of supply chain disruption and margin compression from the threatened tariff and existing contract cancellations.
• It is prudent to review portfolios for any companies reliant on the Brazil-U.S. export corridor, particularly in agriculture and manufacturing, as knock-on effects are already materializing.
• Monitor U.S.-based chemical competitors who may benefit from a shift in sourcing away from Brazil, as this represents a potential pair trade or hedging opportunity against long positions exposed to this specific trade risk.
• The primary catalyst remains the official confirmation or cancellation of the tariff; any political developments from either government should be watched closely as they will directly impact valuations.